Skip to content
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Select Articles Relevant to NVG-291 and Alzheimer's Disease
05 • 08 • 2026
Alzheimer’s disease pathogenesis is dependent on neuronal receptor PTPσ.
05 • 08 • 2026
Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology.
05 • 08 • 2026
Antibody recognizing 4-sulfated chondroitin sulfate proteoglycans restores memory in tauopathy-induced neurodegeneration.
05 • 08 • 2026
Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer’s disease.
No posts found